Vaccination Expands Antigen-Specific CD4+ Memory T Cells and Mobilizes Bystander Central Memory T Cells.
CD4+ T helper memory (Thmem) cells influence both natural and vaccine-boosted immunity, but mechanisms for their maintenance remain unclear. Pro-survival signals from the common gamma-chain cytokines, in particular IL-7, appear important. Previously we showed in healthy volunteers that a booster vaccination with tetanus toxoid (TT) expanded peripheral blood TT-specific Thmem cells as expected, but was accompanied by parallel increase of Thmem cells specific for two unrelated and non cross-reactive common recall antigens. Here, in a new cohort of healthy human subjects, we compare blood vaccine-specific and bystander Thmem cells in terms of differentiation stage, function, activation and proliferative status. Both responses peaked 1 week post-vaccination. Vaccine-specific cytokine-producing Thmem cells were predominantly effector memory, whereas bystander cells were mainly of central memory phenotype. Importantly, TT-specific Thmem cells were activated (CD38High HLA-DR+), cycling or recently divided (Ki-67+), and apparently vulnerable to death (IL-7RαLow and Bcl-2 Low). In contrast, bystander Thmem cells were resting (CD38Low HLA-DR- Ki-67-) with high expression of IL-7Rα and Bcl-2. These findings allow a clear distinction between vaccine-specific and bystander Thmem cells, suggesting the latter do not derive from recent proliferation but from cells mobilized from as yet undefined reservoirs. Furthermore, they reveal the interdependent dynamics of specific and bystander T-cell responses which will inform assessments of responses to vaccines.
Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Eleonora
E
Li Causi
Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Suraj C
SC
Parikh
Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Lindsey
L
Chudley
Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
David M
DM
Layfield
Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Christian H
CH
Ottensmeier
Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Freda K
FK
Stevenson
Cancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Gianfranco
G
Di Genova
D000328:Adult; D015496:CD4-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology*; D049109:Cell Proliferation; D005260:Female; D006801:Humans; D007117:Immunization, Secondary; D007156:Immunologic Memory; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000276:immunology; D020395:Receptors, Interleukin-7 / Q000276:immunology; D013745:Tetanus Toxoid / Q000276:immunology* / Q000627:therapeutic use; D014611:Vaccination
D019253:Proto-Oncogene Proteins c-bcl-2; D020395:Receptors, Interleukin-7; D013745:Tetanus Toxoid; C415350:interleukin-7 receptor, alpha chain